INR 12.49
(1.54%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 799.55 Million INR | 1.33% |
2022 | 789.07 Million INR | -3.33% |
2021 | 816.23 Million INR | -5.22% |
2020 | 861.23 Million INR | 30.09% |
2019 | 662.03 Million INR | -3.7% |
2018 | 687.51 Million INR | 6.88% |
2017 | 643.23 Million INR | 44.07% |
2016 | 446.48 Million INR | -10.29% |
2015 | 497.72 Million INR | 8.69% |
2014 | 457.95 Million INR | -14.29% |
2013 | 534.29 Million INR | 9.98% |
2012 | 485.81 Million INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 Q2 | 801.66 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 799.55 Million INR | 1.33% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 799.55 Million INR | 0.0% |
2022 FY | 789.07 Million INR | -3.33% |
2022 Q4 | 789.07 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 748.72 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 FY | 816.23 Million INR | -5.22% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 816.23 Million INR | 0.0% |
2021 Q2 | 744.36 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q1 | 654.89 Million INR | -1.08% |
2020 Q4 | 861.23 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 861.23 Million INR | 30.09% |
2020 Q2 | 638.84 Million INR | -2.45% |
2019 Q2 | 694.07 Million INR | 0.0% |
2019 FY | 662.03 Million INR | -3.7% |
2019 Q4 | 662.03 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q1 | 608.25 Million INR | -5.44% |
2018 FY | 687.51 Million INR | 6.88% |
2018 Q4 | 687.51 Million INR | 0.0% |
2018 Q3 | 687.51 Million INR | 13.03% |
2018 Q2 | 608.25 Million INR | 0.0% |
2017 FY | 643.23 Million INR | 44.07% |
2017 Q1 | - INR | 0.0% |
2017 Q2 | 576.86 Million INR | 0.0% |
2017 Q4 | 643.23 Million INR | 0.16% |
2017 Q3 | 642.22 Million INR | 11.33% |
2016 FY | 446.48 Million INR | -10.29% |
2015 FY | 497.72 Million INR | 8.69% |
2014 FY | 457.95 Million INR | -14.29% |
2013 FY | 534.29 Million INR | 9.98% |
2012 FY | 485.81 Million INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aarti Drugs Limited | 24.32 Billion INR | 96.713% |
Albert David Limited | 4.97 Billion INR | 83.944% |
Alembic Limited | 23.28 Billion INR | 96.567% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -69.82% |
Hester Biosciences Limited | 6.62 Billion INR | 87.928% |
Hikal Limited | 24.87 Billion INR | 96.785% |
Ind-Swift Limited | 6.54 Billion INR | 87.783% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | 66.694% |
Unichem Laboratories Limited | 31.69 Billion INR | 97.477% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 98.76% |
Bafna Pharmaceuticals Limited | 1.47 Billion INR | 45.859% |
Bajaj HealthCare Limited | 7.65 Billion INR | 89.55% |
Brooks Laboratories Limited | 904.45 Million INR | 11.598% |
Eris Lifesciences Limited | 70.48 Billion INR | 98.866% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 96.593% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | 63.167% |
Wanbury Limited | 3.43 Billion INR | 76.723% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 96.903% |
Alkem Laboratories Limited | 155.74 Billion INR | 99.487% |
FDC Limited | 24.68 Billion INR | 96.76% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 97.195% |
Gufic Biosciences Limited | 10.92 Billion INR | 92.682% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | 93.137% |
Innova Captab Limited | 13.2 Billion INR | 93.947% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 96.438% |
Ipca Laboratories Limited | 111.01 Billion INR | 99.28% |
Jubilant Pharmova Limited | 115.48 Billion INR | 99.308% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | 88.582% |
Lupin Limited | 239.97 Billion INR | 99.667% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | 76.02% |
Medico Remedies Limited | 961.95 Million INR | 16.882% |
Morepen Laboratories Limited | 12.93 Billion INR | 93.817% |
Nectar Lifesciences Limited | 21.91 Billion INR | 96.351% |
Orchid Pharma Limited | 15.53 Billion INR | 94.854% |
Procter & Gamble Health Limited | 7.94 Billion INR | 89.935% |
RPG Life Sciences Limited | 5.12 Billion INR | 84.41% |
Sigachi Industries Limited | 6.94 Billion INR | 88.482% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 99.906% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 96.453% |
Themis Medicare Limited | 5.66 Billion INR | 85.884% |
Venus Remedies Limited | 6.26 Billion INR | 87.244% |
Windlas Biotech Limited | 6.26 Billion INR | 87.232% |
ZIM Laboratories Limited | 4.46 Billion INR | 82.106% |
Sakar Healthcare Limited | 3.88 Billion INR | 79.428% |
Aurobindo Pharma Limited | 450.71 Billion INR | 99.823% |
Divi's Laboratories Limited | 154.7 Billion INR | 99.483% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | 92.583% |
Mankind Pharma Limited | 119.63 Billion INR | 99.332% |
Sequent Scientific Limited | 15.4 Billion INR | 94.809% |
Laurus Labs Limited | 83.87 Billion INR | 99.047% |
Neuland Laboratories Limited | 18.32 Billion INR | 95.637% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 97.998% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 99.443% |
Zydus Lifesciences Limited | 292.8 Billion INR | 99.727% |
Amrutanjan Health Care Limited | 3.66 Billion INR | 78.206% |
Wockhardt Limited | 76.49 Billion INR | 98.955% |
Bal Pharma Limited | 3.2 Billion INR | 75.044% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 99.794% |
Bliss GVS Pharma Limited | 12.13 Billion INR | 93.413% |
Par Drugs and Chemicals Limited | 1.01 Billion INR | 21.312% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 97.036% |
Shilpa Medicare Limited | 30.93 Billion INR | 97.415% |
Valiant Laboratories Limited | 3.42 Billion INR | 76.668% |
Ajanta Pharma Limited | 46.38 Billion INR | 98.276% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | 73.784% |
Granules India Limited | 55.2 Billion INR | 98.552% |
Medicamen Biotech Limited | 2.94 Billion INR | 72.852% |
Syncom Formulations (India) Limited | 4.04 Billion INR | 80.241% |
Piramal Enterprises Limited | 826.05 Billion INR | 99.903% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 99.469% |
NATCO Pharma Limited | 69.06 Billion INR | 98.842% |
Suven Life Sciences Limited | 2.84 Billion INR | 71.936% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | 55.125% |
Strides Pharma Science Limited | 58.39 Billion INR | 98.631% |
Indoco Remedies Limited | 21.44 Billion INR | 96.272% |
Alpa Laboratories Limited | 1.82 Billion INR | 56.218% |
Lasa Supergenerics Limited | 1.5 Billion INR | 47.003% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | 84.476% |